Pacer Advisors’s Regenxbio RGNX Stock Holding History
Bought
Maintained
Sold
Other funds holding RGNX
RG
IHAM
APM
Pacer Advisors's RGNX Position: Q3 2024 in Review
Pacer Advisors sold out of Regenxbio (RGNX) in Q3 2024, closing a stake of 587 shares — an estimated $6.87K sold.
Pacer Advisors first reported a position in RGNX in Q4 2017 and held it in 7 quarters. The position peaked at $227K in Q3 2018. 186 funds tracked by Wall St. Rank hold RGNX as of Q3 2024.
- Pacer Advisors reported no remaining Regenxbio position as of Q3 2024 after selling out during the quarter.
- Pacer Advisors sold 587 Regenxbio shares in Q3 2024, an estimated $6.87K.
- Pacer Advisors first reported a position in Regenxbio in Q4 2017 and held it in 7 quarters.
- Pacer Advisors's Regenxbio position peaked at $227K in Q3 2018.
- 186 funds tracked by Wall St. Rank held Regenxbio as of Q3 2024.
Based on Pacer Advisors's 13F filing for Q3 2024, filed 12 Nov 2024.